-
Young Kwak/APThere are at least three fires in and around the city. Large parts of Spokane are under Level 3 evacuation orders, which read: "Leave NOW! This may be your only notice." -
Ellen M. Banner/The Seattle TimesAn 18-month investigation by The Seattle Times, KUOW and NPR's Embedded podcast and a review of more than a dozen videos from the night of the shooting reveal the most comprehensive view to date of how the chaotic scene unfolded. And they show how a Black teenager who came to join the civil rights movement of his generation — in a zone abandoned by police — ended up killed by a protest movement that thought he was a threat.
-
About 1 in 4 babies in the Pakistani fishing settlement of Rehri Goth are born prematurely. Researchers are trying to figure out how to bring the numbers down. -
Laila AnnMarie Stevens documents her family's move from New York City to North Carolina — a kind of reversal of the historic Great Migration of the early 20th century. -
NPR asked an aspiring scientist in Philadelphia to interview an adult who is living his dream about his career in conservation science. -
Cyclospora, the parasite that has sickened thousands this summer in the U.S., requires time in the human digestive tract to reproduce.
Adam Lau
/
AP
Police who responded to the shooting found the body of the suspected gunman in an area near the restaurant.
-
A mountaineering team with climbers from around the world, including the U.S., was attempting to climb one of the tallest peaks on earth. -
Ballistic missiles tore into five districts of the Ukrainian capital before dawn Saturday. President Trump is now walking back a promised boost to Ukraine's missile defense systems. -
The pro-immigration leader is facing backlash at home and abroad after roughly 60,000 people crossed from Morocco into the Spanish enclave. -
It's a bold new experiment and it's already won a prize. Residents in a jam-packed slum, many of them living in one-room tin shacks, help design their apartments in a brand new building. -
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
